SYNLAB Eesti OÜ
SYNLAB Eesti OÜ is a OÜ based in Tallinn, registry code 11107913, status: active. Main activity: Diagnostic imaging services and medical laboratory activities. According to EMTA, turnover for Q3 2026 was €1 071 942 with 307 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 1.1 mn €above 98% of companiesindustry median 9 428 € · companies in the industry: 351
- Labour taxes per employee 4 029 €above 77% of companiesindustry median 2 177 € · companies in the industry: 1 696
- Revenue · 2025 43.3 mn €above 98% of companiesindustry median 20 811 € · companies in the industry: 3 373
- Net profit margin · 2025 29.6 %above 77% of companiesindustry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 1 071 942 | 1 346 575 | 1 236 928 | 307 |
| Q2 2026 | 1 384 165 | 1 733 080 | 1 570 695 | 316 |
| Q1 2026 | 1 156 869 | 2 515 517 | 1 269 494 | 304 |
| Q4 2025 | 1 245 943 | 1 438 039 | 1 255 568 | 302 |
| Q3 2025 | 1 157 020 | 1 413 203 | 1 287 948 | 312 |
| Q2 2025 | 1 288 145 | 1 730 863 | 1 586 172 | 323 |
| Q1 2025 | 1 329 503 | 3 629 522 | 1 398 983 | 312 |
| Q4 2024 | 1 228 212 | 1 364 083 | 1 184 661 | 321 |
| Q3 2024 | 869 656 | 1 866 273 | 1 560 032 | 321 |
| Q2 2024 | 1 155 139 | 1 744 133 | 1 611 939 | 321 |
| Q1 2024 | 1 336 627 | 3 419 011 | 1 222 869 | 321 |
| Q4 2023 | 1 035 756 | 1 233 471 | 1 139 214 | 318 |
| Q3 2023 | 1 202 500 | 1 351 703 | 1 228 390 | 326 |
| Q2 2023 | 998 347 | 1 548 878 | 1 492 853 | 332 |
| Q1 2023 | 1 554 220 | 1 398 164 | 1 267 757 | 322 |
| Q4 2022 | 2 514 421 | 7 910 676 | 1 267 680 | 373 |
| Q3 2022 | 1 467 630 | 1 462 946 | 1 307 319 | 427 |
| Q2 2022 | 1 925 435 | 2 030 162 | 1 862 922 | 449 |
| Q1 2022 | 4 227 672 | 2 747 220 | 2 137 336 | 500 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 43 258 391 | 12 794 868 | 12 516 238 | 46 443 079 | 40 654 425 | 259 |
| 2024 | 41 460 971 | 9 418 420 | 13 753 619 | 38 586 362 | 31 859 557 | 265 |
| 2023 | 37 714 808 | 8 149 332 | 11 880 007 | 41 914 658 | 34 739 137 | 274 |
| 2022 | 62 988 586 | 14 661 609 | 14 050 140 | 45 255 867 | 38 887 805 | 346 |
| 2021 | 100 965 740 | 38 217 513 | 17 687 249 | 64 353 401 | 52 226 196 | 381 |
| 2020 | 69 846 811 | 27 488 475 | 11 526 361 | 66 015 539 | 34 008 683 | 266 |
| 2019 | 26 485 571 | 4 271 711 | 7 504 838 | 34 455 012 | 9 720 208 | 222 |
| 2018 | — | — | — | — | — | 206 |
| 2017 | — | — | — | — | — | 190 |
| 2016 | — | — | — | — | — | 165 |
| 2015 | — | — | — | — | — | 152 |
| 2014 | — | — | — | — | — | 147 |
| 2013 | — | — | — | — | — | 144 |
| 2012 | — | — | — | — | — | 98 |
| 2011 | — | — | — | — | — | 82 |
| 2010 | — | — | — | — | — | 57 |
| 2009 | — | — | — | — | — | 56 |
| 2008 | — | — | — | — | — | 57 |
| 2007 | — | — | — | — | — | 55 |
| 2006 | — | — | — | — | — | 46 |
| 2005 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 1 Jul 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 1 Jul 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 30 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 18 Jul 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 28 Nov 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 31 Oct 2020 | Company’s own · audited | e-Äriregister |
Board
- Kaido BeljaevBoard member · since 13 Feb 2009
- Rainar AamiseppBoard member · since 23 Mar 2010
- Nasdaq CSD SEKeeper of the share register · since 28 Sep 2017
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Omanikukonto: SYNLAB INTERNATIONAL GMBHLegal person · 2 566 €
Beneficial owners
- Mathieu Oliver FloreaniMember of a senior management body (management or supervisory board) · DEU · since 26 Nov 2018
Founders and other persons
- Icosagen ASFounder · 40 000 € · 11 Apr 2005
- Erki UsinAudit firm · 19 Sep 2017
- Aktsiaselts Deloitte Audit EestiAudit firm · 19 Sep 2017
Related companies
Activities (EMTAK)
- 86911Diagnostic imaging services and medical laboratory activities Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 20028771 / 29 5 Feb 2021 |
Amendment entry | In force 5 Feb 2021 |
||
| Ä 20028771 / 28 6 Oct 2020 |
Amendment entry | In force 6 Oct 2020 |
||
| Ä 20028771 / 27 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 20028771 / M9 28 Dec 2017 |
Ruling to eliminate deficiencies | 27 Jan 2018 | Deficiencies eliminated 28 Dec 2017 |
|
| Ä 20028771 / 26 3 Dec 2017 |
Amendment entry | In force 3 Dec 2017 |
||
| Ä 20028771 / 25 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 20028771 / 24 27 Jun 2017 |
Amendment under Commercial Code § 525 (2) | In force 27 Jun 2017 |
||
| Ä 20028771 / 23 2 Jan 2017 |
Amendment entry | In force 2 Jan 2017 |
||
| Ä 20028771 / 22 8 Sep 2016 |
Amendment entry | In force 8 Sep 2016 |
||
| Ä 20028771 / 21 3 Aug 2016 |
Amendment entry | In force 3 Aug 2016 |
||
| Ä 20028771 / M8 10 Jul 2016 |
Ruling to eliminate deficiencies | 9 Aug 2016 | Deficiencies eliminated 3 Aug 2016 |
|
| Ä 20028771 / M7 4 Jan 2016 |
Ruling to correct data outside an entry | 3 Feb 2016 | Deficiencies eliminated 4 Jan 2016 |
|
| Ä 20028771 / 20 29 Dec 2015 |
Amendment entry | In force 29 Dec 2015 |
||
| Ä 20028771 / 19 18 May 2015 |
Amendment entry | In force 18 May 2015 |
||
| Ä 20028771 / 18 31 Jul 2014 |
Amendment entry | In force 31 Jul 2014 |
||
| Ä 20028771 / M6 29 Jul 2014 |
Ruling to eliminate deficiencies | 28 Aug 2014 | Deficiencies eliminated 31 Jul 2014 |
|
| Ä 20028771 / 17 28 Apr 2014 |
Amendment entry | In force 28 Apr 2014 |
||
| Ä 20028771 / 16 16 Apr 2014 |
Amendment entry | In force 16 Apr 2014 |
||
| Ä 20028771 / M5 7 Apr 2014 |
Ruling to eliminate deficiencies | 7 May 2014 | Deficiencies eliminated 15 Apr 2014 |
|
| Ä 20028771 / 15 16 Dec 2013 |
Second (constitutive) merger entry | In force 16 Dec 2013 |
||
| K 20028771 / 14 23 Aug 2013 |
Commercial pledge deleted | In force 23 Aug 2013 |
||
| Ä 20028771 / 13 26 Feb 2013 |
Amendment entry | In force 26 Feb 2013 |
||
| K 20028771 / 12 30 Jan 2013 |
Commercial pledge entered | In force 30 Jan 2013 |
||
| Ä 20028771 / 11 30 May 2011 |
Amendment entry | In force 30 May 2011 |
||
| Ä 20028771 / M4 18 May 2011 |
Ruling to eliminate deficiencies | 30 May 2011 | In force 18 May 2011 |
|
| K 20036656 / 5 7 Oct 2010 |
Commercial pledge entered | In force 7 Oct 2010 |
||
| K 20036656 / 4 7 Oct 2010 |
Commercial pledge amended | In force 7 Oct 2010 |
||
| K 20036656 / M2 5 Oct 2010 |
Ruling to eliminate deficiencies | 4 Nov 2010 | In force 5 Oct 2010 |
|
| Ä 20028771 / 10 23 Mar 2010 |
Amendment entry | In force 23 Mar 2010 |
||
| K 36656 / 3 1 Apr 2009 |
Commercial pledge amended | In force 1 Apr 2009 |
||
| Ä 28771 / 9 13 Feb 2009 |
Amendment entry | In force 13 Feb 2009 |
||
| Ä 28771 / M3 11 Feb 2009 |
Ruling to eliminate deficiencies | In force 11 Feb 2009 |
||
| Ä 28771 / 8 3 Dec 2008 |
Deletion of activities from the registry card | In force 23 Dec 2008 |
||
| Ä 28771 / 7 10 Oct 2008 |
Amendment entry | In force 10 Oct 2008 |
||
| K 36656 / 2 3 Sep 2008 |
Commercial pledge amended | In force 3 Sep 2008 |
||
| K 36656 / M1 29 Aug 2008 |
Ruling to eliminate deficiencies (to be served) | 3 Oct 2008 | In force 3 Sep 2008 |
|
| Ä 28771 / 6 26 Aug 2008 |
Entry made by the register on its own initiative | In force 26 Aug 2008 |
||
| Ä 28771 / 5 31 Dec 2007 |
Amendment entry | In force 31 Dec 2007 |
||
| Ä 28771 / M2 27 Dec 2007 |
Ruling to eliminate deficiencies (to be served) | 26 Jan 2008 | In force 27 Dec 2007 |
|
| Ä 28771 / 4 9 Feb 2007 |
Amendment entry | In force 9 Feb 2007 |
||
| Ä 28771 / M1 16 Jan 2007 |
Ruling to eliminate deficiencies (to be served) | 17 Feb 2007 | In force 18 Jan 2007 |
|
| Ä 28771 / 3 2 Oct 2006 |
Second (constitutive) merger entry | In force 10 Oct 2006 |
||
| K 36656 2 Oct 2006 |
Commercial pledge entered | In force 10 Oct 2006 |
||
| Ä 28771 / 2 6 Sep 2006 |
Entry made by the register on its own initiative | In force 6 Sep 2006 |
||
| Ä 28771 14 Apr 2005 |
First entry | In force |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data